title: Phase I/II evaluation of effervescent and enteric coated oral pamidronate for bone metastases.
authors.forename: R E
authors.initials: RE
authors.lastname: Coleman
authors.forename: L Y
authors.initials: LY
authors.lastname: Dirix
authors.forename: D
authors.initials: D
authors.lastname: Dodwell
authors.forename: M
authors.initials: M
authors.lastname: Tubiana-Hulin
authors.forename: J J
authors.initials: JJ
authors.lastname: Body
authors.forename: R
authors.initials: R
authors.lastname: Becher
authors.forename: G K
authors.initials: GK
authors.lastname: White
authors.forename: R D
authors.initials: RD
authors.lastname: Rubens
authors.forename: A
authors.initials: A
authors.lastname: Van Oosterom
authors.forename: A
authors.initials: A
authors.lastname: Howell
mesh_terms: D000284:Administration, Oral; D001859:Bone Neoplasms / Q000188:drug therapy / Q000556:secondary*; D004164:Diphosphonates / Q000008:administration & dosage; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008875:Middle Aged; D000077268:Pamidronate; D013608:Tablets, Enteric-Coated
chemical_list: D004164:Diphosphonates; D013608:Tablets, Enteric-Coated; D000077268:Pamidronate